Rchr
J-GLOBAL ID：202201017240327415
Update date: Sep. 15, 2024
Sin Yooksil
シン イクミ | Sin Yooksil
Affiliation and department：
Other affiliations (1)：
-
Tokyo Medical and Dental University
Research field (1)：
Molecular biology
Research keywords (4)：
機械学習
, mRNA医薬
, rare cancer
, sarcoma
Research theme for competitive and other funds (1)：
- 2021 - 2024 PAX7-FOXO1胞巣型横紋筋肉腫の治療法の開発; 患者由来癌モデルを使う研究
Papers (51)：
-
Yuki Yoshimatsu, Rei Noguchi, Julia Osaki, Yooksil Sin, Ryuto Tsuchiya, Takuya Ono, Taro Akiyama, Yuki Adachi, Yoshikazu Tanzawa, Akihiko Yoshida, et al. Establishment and characterization of NCC-LMS3-C1: a novel patient-derived cell line of leiomyosarcoma. Human cell. 2024. 37. 1. 337-344
-
Rei Noguchi, Yuki Yoshimatsu, Yooksil Sin, Takuya Ono, Ryuto Tsuchiya, Hiroshi Yoshida, Tohru Kiyono, Yutaka Yonemura, Tadashi Kondo. Establishment and characterization of NCC-PMP2-C1: a novel patient-derived cell line of pseudomyxoma peritonei with signet ring cells. Human Cell. 2023. 37. 2. 511-522
-
Rei Noguchi, Yuki Yoshimatsu, Yooksil Sin, Takuya Ono, Ryuto Tsuchiya, Hiroshi Yoshida, Tohru Kiyono, Yutaka Yonemura, Tadashi Kondo. Correction: Noguchi et al. Establishment and Characterization of NCC-PMP1-C1: A Novel Patient-Derived Cell Line of Metastatic Pseudomyxoma Peritonei. J. Pers. Med. 2022, 12, 258. Journal of personalized medicine. 2023. 13. 9
-
Takuya Ono, Rei Noguchi, Yuki Yoshimatsu, Yooksil Sin, Ryuto Tsuchiya, Taro Akiyama, Naoki Kojima, Yu Toda, Chiaki Sato, Suguru Fukushima, et al. Establishment and characterization of two novel patient-derived cell lines from giant cell tumor of bone. Human cell. 2023. 36. 5. 1804-1812
-
Taro Akiyama, Yuki Yoshimatsu, Rei Noguchi, Yooksil Sin, Julia Osaki, Takuya Ono, Yuki Adachi, Ryuto Tsuchiya, Yu Toda, Koichi Ogura, et al. Establishment and characterization of NCC-DFSP4-C1: a novel cell line from a patient with dermatofibrosarcoma protuberans having the fibrosarcomatous transformation. Human cell. 2023. 36. 6. 2187-2194
ｍore...
MISC (34)：
-
Ono Takuya, Ono Takuya, Noguchi Rei, Yoshimatsu Yuki, Tsuchiya Ryuto, Sin Yooksil, Nakagawa Rumi, Hirabayashi Kaoru, Ozawa Iwao, Kikuta Kazutaka, et al. Establishment and characterization of the NCC-GCTB4-C1 cell line: a novel patient-derived cell line from giant cell tumor of bone. Human Cell (Web). 2022. 35. 1
-
Tsuchiya Ryuto, Tsuchiya Ryuto, Yoshimatsu Yuki, Noguchi Rei, Sin Yooksil, Ono Takuya, Akiyama Taro, Akiyama Taro, Sugaya Jun, Nakatani Fumihiko, et al. Establishment and characterization of NCC-UPS3-C1: a novel patient-derived cell line of undifferentiated pleomorphic sarcoma. Human Cell (Web). 2022. 35. 1
-
Sin Yooksil, Yoshimatsu Yuki, Noguchi Rei, Tsuchiya Ryuto, Tsuchiya Ryuto, Ono Takuya, Akiyama Taro, Akiyama Taro, Nakatani Fumihiko, Sugaya Jun, et al. Establishment and characterization of NCC-MPNST6-C1: a novel patient-derived cell line of malignant peripheral nerve sheath tumors. Human Cell (Web). 2022. 35. 1
-
土屋流人, 土屋流人, 野口玲, 吉松有紀, SIN Y., 小野拓也, 清茜, 小迫英尊, 川井章, 近藤格. Novel candidate drugs for the treatment of Malignant peripheral nerve sheath tumor revealed by mass spectrometry and drug screening using patient-derived cell lines. 日本プロテオーム学会大会プログラム・抄録集. 2021. 2021 (CD-ROM)
-
野口玲, 吉松有紀, SIN Y, 小野拓也, 土屋流人, 小迫英尊, 近藤格. OncoProGx~innovative software generating sample-specific database for proteogenomics. 日本プロテオーム学会大会プログラム・抄録集. 2021. 2021 (CD-ROM)
ｍore...
Education (1)：
- Osaka University Graduate School of Frontier Biosciences
Work history (4)：
- 2023/02 - 現在 Tokyo Medical and Dental University
- 2023/02 - 現在 Osaka University
- 2020/01 - 2023/01 National Cancer Center Institute division of rare cancer research researcher
- 2015/04 - 2018/03 National Institutes of Biomedical Innovation, Health and Nutrition Laboratory of XNA Screening and Design researcher
Return to Previous Page
